Form 4: Ideaya Biosciences Director Wendy L. Yarno Reports Stock Option Grant

Director Wendy L. Yarno of Ideaya Biosciences reports the acquisition of stock options.

Summary

• On May 31, 2024, Wendy L. Yarno, a director of IDEAYA Biosciences, Inc., reported the acquisition of stock options.
• The stock option grants the right to buy 16,200 shares of common stock at an exercise price of $36.55.
• The options vest on the earlier of the first anniversary of the grant date or immediately prior to the next Annual Meeting, contingent upon continued service on the Board.
• A Power of Attorney was executed on May 22, 2024, granting certain officers of Ideaya Biosciences the authority to act on behalf of Wendy L. Yarno in matters related to SEC filings.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the sentiment is neutral.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the Board.

Future Outlook

The director's holdings and transactions will continue to be reported as required by SEC regulations.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value.

Stakeholder Impact

• The stock option grant could potentially impact shareholder value depending on the future performance of the company's stock.

Key Dates